Figure 1
Trial design of AML16 (acute myeloid leukemia; intensive arm) from 2006 to 2009. C, course; CR, complete remission; PR, partial remission; Rx, treatment.
Figure 1 | Leukemia
Trial design of AML16 (acute myeloid leukemia; intensive arm) from 2006 to 2009. C, course; CR, complete remission; PR, partial remission; Rx, treatment.
